WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS

This group comprises preparations used in the treatment of Parkinsons disease and related conditions, including drug-induced parkinsonism.

The DDDs are based on recommended doses for the long-term treatment of symptoms of Parkinsons disease.

No separate DDDs are established for oral depot formulations.


N04B DOPAMINERGIC AGENTS
N04BA Dopa and dopa derivatives

Combinations with decarboxylase inhibitors and other dopaminergic agents are classified here.

The DDD for the combination of levodopa and decarboxylase inhibitor is based on the content of levodopa, see ATC index.


List of abbreviations

Last updated: 2016-12-20